Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 Am J Clin Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Emerging Futuristic Targeted Therapeutics: A Comprising Study Towards a New Era
for the Management of TNBC.
Am J Clin Oncol. 2024;47:132-148.
PubMed
Abstract available
Exposure to Per- and Polyfluoroalkyl Substances and Breast Cancer Risk: A
Systematic Review and Meta-analysis of Epidemiologic Studies.
Am J Epidemiol. 2024 Feb 23:kwae010. doi: 10.1093.
PubMed
Abstract available
Should surgeons reconsider the role of intraoperative sentinel lymph node
evaluation for premenopausal breast cancer patients in the era of RxPONDER?
Am J Surg. 2024 Feb 17:S0002-9610(24)00123-5. doi: 10.1016/j.amjsurg.2024.
PubMed
Latissimus dorsi flap with immediate fat transfer (LIFT) for autologous breast
reconstruction: Single institution experience.
Am J Surg. 2024;228:185-191.
PubMed
Abstract available
Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic
breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET.
Ann Oncol. 2024 Feb 27:S0923-7534(24)00057-7. doi: 10.1016/j.annonc.2024.
PubMed
Abstract available
SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We
Ready to Change the Tune of Our Breast Cancer Practice?
Ann Surg Oncol. 2024 Feb 28. doi: 10.1245/s10434-024-15111.
PubMed
Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After
Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management
Changes?
Ann Surg Oncol. 2024 Mar 1. doi: 10.1245/s10434-024-15052.
PubMed
Abstract available
Co-treatment With Aripiprazole and Vincristine Sensitizes
P-Glycoprotein-Overexpressing Drug-resistant MCF-7/ADR Breast Cancer Cells.
Anticancer Res. 2024;44:1051-1062.
PubMed
Abstract available
Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the
Down-regulation of Estrogen Receptor alpha.
Anticancer Res. 2024;44:1109-1120.
PubMed
Abstract available
Effectiveness of Rhenium(I)-diselenoether Low Doses in a Triple-negative Breast
Cancer Chicken Embryo Model.
Anticancer Res. 2024;44:941-951.
PubMed
Abstract available
Methyl Jasmonate-induced Increase in Intracellular Magnesium Promotes Apoptosis
in Breast Cancer Cells.
Anticancer Res. 2024;44:1087-1095.
PubMed
Abstract available
Radiation-induced angiosarcoma of the breast: retrospective analysis at a
regional treatment centre.
Breast Cancer. 2024;31:272-282.
PubMed
Abstract available
Patient-reported outcomes of mesh in minimally invasive
(laparoscopic/robot-assisted) immediate subpectoral prosthesis breast
reconstruction: a retrospective study.
Breast Cancer. 2024;31:243-251.
PubMed
Abstract available
Reliability and validity of the Japanese version of the Chemotherapy-induced
Alopecia Distress Scale.
Breast Cancer. 2024;31:234-242.
PubMed
Abstract available
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers
using a comprehensive genomic profiling assay in Taiwan.
Breast Cancer. 2024;31:217-227.
PubMed
Abstract available
SIRT1 mediates breast cancer development and tumorigenesis controlled by
estrogen-related receptor beta.
Breast Cancer. 2024 Feb 29. doi: 10.1007/s12282-024-01555.
PubMed
Abstract available
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a
comparison with stereotactic vacuum assisted biopsy.
Breast Cancer. 2024;31:329-334.
PubMed
Abstract available
The effects of breast density on the benefits of mammograms with adjunctive
ultrasonography in breast screening.
Breast Cancer. 2024;31:228-233.
PubMed
Abstract available
Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging
Therapeutic Options.
Breast Cancer (Auckl). 2024;18:11782234241234418.
PubMed
Abstract available
Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in
estrogen receptor-positive breast cancer overcomes tamoxifen resistance.
Breast Cancer Res. 2024;26:33.
PubMed
Abstract available
PTHrP intracrine actions divergently influence breast cancer growth through p27
and LIFR.
Breast Cancer Res. 2024;26:34.
PubMed
Abstract available
A phase 1b study of zilovertamab in combination with paclitaxel for locally
advanced/unresectable or metastatic Her2-negative breast cancer.
Breast Cancer Res. 2024;26:32.
PubMed
Abstract available
Augmented interpretation of HER2, ER, and PR in breast cancer by artificial
intelligence analyzer: enhancing interobserver agreement through a reader study
of 201 cases.
Breast Cancer Res. 2024;26:31.
PubMed
Abstract available
Opportunities for personalised follow-up in breast cancer: the gap between daily
practice and recurrence risk.
Breast Cancer Res Treat. 2024 Feb 26. doi: 10.1007/s10549-024-07246.
PubMed
Abstract available
Pro-vegetarian dietary pattern and risk of breast cancer: a case-control study.
Breast Cancer Res Treat. 2024 Feb 28. doi: 10.1007/s10549-024-07243.
PubMed
Abstract available
Development of a core outcome set for breast cancer-related lymphedema: a Delphi
study.
Breast Cancer Res Treat. 2024 Feb 29. doi: 10.1007/s10549-024-07262.
PubMed
Abstract available
Liver tropism of ER mutant breast cancer is characterized by unique molecular
changes and immune infiltration.
Breast Cancer Res Treat. 2024 Mar 1. doi: 10.1007/s10549-024-07255.
PubMed
Abstract available
Mammoplasty Using Modified Superomedial Pedicle Technique in Severely Macromastia
and Ptotic Breasts.
Breast J. 2024;2024:7635485.
PubMed
Abstract available
An ultrasound-based nomogram for predicting axillary node pathologic complete
response after neoadjuvant chemotherapy in breast cancer: Modeling and external
validation.
Cancer. 2024 Mar 1. doi: 10.1002/cncr.35248.
PubMed
Abstract available
Triple-negative breast cancer survival prediction using artificial intelligence
through integrated analysis of tertiary lymphoid structures and tumor budding.
Cancer. 2024 Feb 29. doi: 10.1002/cncr.35261.
PubMed
Abstract available
FDA approves capivasertib with fulvestrant for breast cancer.
Cancer. 2024;130:835-836.
PubMed
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in
patients with BRCA-mutated advanced solid tumors.
Cancer Chemother Pharmacol. 2024;93:177-189.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Breast cancer stage and size detected with film versus digital mammography in New
South Wales, Australia: a population-based study using routinely collected data.
Cancer Epidemiol Biomarkers Prev. 2024.
PubMed
Abstract available
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are
sensitive to synergistic combination PARP inhibitor treatment.
Cancer Lett. 2024;584:216608.
PubMed
Abstract available
Clinical sequencing defines the somatic and germline mutation landscapes of
Chinese HER2-Low Breast Cancer.
Cancer Lett. 2024 Feb 23:216763. doi: 10.1016/j.canlet.2024.216763.
PubMed
Abstract available
CD63(+) cancer-associated fibroblasts confer CDK4/6 inhibitor resistance to
breast cancer cells by exosomal miR-20.
Cancer Lett. 2024 Feb 23:216747. doi: 10.1016/j.canlet.2024.216747.
PubMed
Abstract available
A Comprehensive Assessment of Radial Scars on Core Needle Biopsy in Patients with
or without Breast Cancer: Upgrade Rate and Implications on Management.
Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00035.
PubMed
Abstract available
Re: "Diagnostic Delays in Breast Cancer Among Young Women: An Emphasis on
Healthcare Providers" by Costa et al.
Clin Breast Cancer. 2024 Feb 6:S1526-8209(24)00038.
PubMed
Prognosis and Adjusting Factors in Elderly Patients With Triple-Negative Breast
Cancer: Comparing With Young and Middle Age Groups.
Clin Breast Cancer. 2024 Jan 30:S1526-8209(24)00027.
PubMed
Abstract available
The Impact of miRNAs on the Efficacy of Tamoxifen in Breast Cancer Treatment: A
Systematic Review.
Clin Breast Cancer. 2024 Jan 26:S1526-8209(24)00026.
PubMed
Abstract available
Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT
and Prognostic Histopathological Factors and Biomarkers in Breast Cancer.
Clin Breast Cancer. 2024 Feb 1:S1526-8209(24)00037.
PubMed
Abstract available
Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course
on fluorescence-guided surgery.
Eur J Surg Oncol. 2024;50:107317.
PubMed
Abstract available
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard
breast conservation and skin-sparing mastectomy in DCIS - a register-based study.
Eur J Surg Oncol. 2024;50:107938.
PubMed
Abstract available
How do AI markings on screening mammograms correspond to cancer location? An
informed review of 270 breast cancer cases in BreastScreen Norway.
Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10662.
PubMed
Abstract available
Corrigendum to "MEX3A promotes development and progression of breast cancer
through regulation of PIK3CA" [Exp. Cell Res. 2021 Jul 1;404(1):112580. Epub 2021
Apr 1.].
Exp Cell Res. 2024;436:113964.
PubMed
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target
for breast cancer.
Int J Oncol. 2024;64:43.
PubMed
Abstract available
Accelerated Partial Breast Irradiation Using 5 Daily Fractions: A Prospective,
Phase 2, Multicenter Trial of Cosmetic Outcomes and Toxicity-ACCEL Final Results.
Int J Radiat Oncol Biol Phys. 2024;118:1041-1048.
PubMed
Abstract available
Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of
Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation
Therapy After Breast-Conserving Surgery.
Int J Radiat Oncol Biol Phys. 2024;118:1049-1059.
PubMed
Abstract available
Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic
Review.
Int J Radiat Oncol Biol Phys. 2024;118:891-899.
PubMed
Abstract available
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in
Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant
Chemotherapy.
J Clin Oncol. 2024 Feb 23:JCO2301199. doi: 10.1200/JCO.23.01199.
PubMed
Abstract available
Erratum: Pathologic Exploration of the Axillary Soft Tissue Microenvironment and
Its Impact on Axillary Management and Breast Cancer Outcomes.
J Clin Oncol. 2024 Feb 23:JCO2400317. doi: 10.1200/JCO.24.00317.
PubMed
Toward Application of Polygenic Risk Scores to Both Enhance and Deintensify
Breast Cancer Screening.
J Clin Oncol. 2024 Feb 29:JCO2400029. doi: 10.1200/JCO.24.00029.
PubMed
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic
Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal
Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.
J Clin Oncol. 2024 Feb 29:JCO2301409. doi: 10.1200/JCO.23.01409.
PubMed
Abstract available
Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in
Women.
J Clin Oncol. 2024 Feb 29:JCO2300295. doi: 10.1200/JCO.23.00295.
PubMed
Abstract available
Multi-tissue transcriptome-wide association studies identified 235 genes for
intrinsic subtypes of breast cancer.
J Natl Cancer Inst. 2024 Feb 23:djae041. doi: 10.1093.
PubMed
Abstract available
Non-surgical ablation for breast cancer: an emerging therapeutic option.
Lancet Oncol. 2024;25:e114-e125.
PubMed
Abstract available
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic
Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Mod Pathol. 2024;37:100375.
PubMed
Abstract available
A Preliminary Investigation into Search and Matching for Tumor Discrimination in
World Health Organization Breast Taxonomy Using Deep Networks.
Mod Pathol. 2024;37:100381.
PubMed
Abstract available
Circulating tumor cells in early lobular versus ductal breast cancer and their
associations with prognosis.
NPJ Breast Cancer. 2024;10:17.
PubMed
Abstract available
Deep learning infers clinically relevant protein levels and drug response in
breast cancer from unannotated pathology images.
NPJ Breast Cancer. 2024;10:18.
PubMed
Abstract available
DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron
translocation and metastatic outgrowth.
Oncogene. 2024;43:650-667.
PubMed
Abstract available
Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through
phosphorylation of ERalpha in breast cancer.
Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02983.
PubMed
LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin
resistance.
Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02972.
PubMed
Abstract available
Correction: Modeling invasive breast cancer: growth factors propel progression of
HER2-positive premalignant lesions.
Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02990.
PubMed
Human endogenous retroviruses (HERVs) in breast cancer: altered expression
pattern implicates divergent roles in carcinogenesis.
Oncology. 2024 Feb 26. doi: 10.1159/000538021.
PubMed
Abstract available
Inhaled anesthesia associated with reduced mortality in patients with stage III
breast cancer: A population-based study.
PLoS One. 2024;19:e0289519.
PubMed
Abstract available
Multi-level barriers to early detection of breast cancer among rural midlife
women in Tanzania: A qualitative case study.
PLoS One. 2024;19:e0297798.
PubMed
Abstract available
A xenotransplantation mouse model to study physiology of the mammary gland from
large mammals.
PLoS One. 2024;19:e0298390.
PubMed
Abstract available
Cuproptosis-associated ncRNAs predict breast cancer subtypes.
PLoS One. 2024;19:e0299138.
PubMed
Abstract available
Nutraceuticals known to promote hair growth do not interfere with the inhibitory
action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
PLoS One. 2024;19:e0297080.
PubMed
Abstract available
Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced
toxicity in patients with early breast cancer.
PLoS One. 2024;19:e0298928.
PubMed
Abstract available
Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug
synergy.
PLoS One. 2024;19:e0298788.
PubMed
Abstract available
Thank you for your interest in scientific medicine.